{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T14:20:53Z","timestamp":1781360453935,"version":"3.54.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s13760-020-01402-6","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T07:02:46Z","timestamp":1592463766000},"page":"1017-1019","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A rare case of Opsoclonus-Myoclonus associated with SCLC"],"prefix":"10.1007","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4038-6783","authenticated-orcid":false,"given":"M.","family":"Lebeer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Coito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Reynders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"key":"1402_CR1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00415-018-9138-7","volume":"266","author":"S-SY Oh","year":"2019","unstructured":"Oh S-SY, Kim J-S, Dieterich M et al (2019) Update on opsoclonus-myoclonus syndrome in adults. J Neurol 266:1541\u20131548","journal-title":"J Neurol"},{"key":"1402_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0022-510X(01)00564-0","volume":"189","author":"AM Wong","year":"2001","unstructured":"Wong AM, Mussalam S, Tomlinson RD et al (2001) Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates. J Neurol Sci 189:71\u201381","journal-title":"J Neurol Sci"},{"issue":"4","key":"1402_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/jamaneurol.2015.4607","volume":"73","author":"T Armangu\u00e9","year":"2016","unstructured":"Armangu\u00e9 T, Sabater L, Torres-Vega E et al (2016) Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies. JAMA Neurol 73(4):417\u2013424","journal-title":"JAMA Neurol"},{"issue":"2","key":"1402_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/brain\/124.2.437","volume":"124","author":"L Bataller","year":"2001","unstructured":"Bataller L, GrausF SA et al (2001) Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus\u2013myoclonus. Brain 124(2):437\u2013443","journal-title":"Brain"},{"key":"1402_CR5","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","volume":"379","author":"L Horn","year":"2018","unstructured":"Horn L, Mansfield A, Mok T et al (2018) First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer (IMPOWER 133). N Engl J Med 379:2220\u20132229","journal-title":"N Engl J Med"},{"issue":"10212","key":"1402_CR6","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","volume":"394","author":"L Paz-Ares","year":"2019","unstructured":"Paz-Ares L, Dvorkin M, Chen Y et al (2019) Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small\u2013cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase 3 trial. Lancet 394(10212):1929\u20131939","journal-title":"Lancet"},{"issue":"9","key":"1402_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","volume":"16","author":"F Graus","year":"2019","unstructured":"Graus F, Dalmau J (2019) Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nat Rev Clin Oncol 16(9):535\u2013548","journal-title":"Nat Rev Clin Oncol"},{"key":"1402_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2352-4642(17)30130-X","volume":"2","author":"PA de Alarcon","year":"2018","unstructured":"de Alarcon PA, Matthay KK, London WB et al (2018) Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. Lancet Child Adolesc 2:25\u201334","journal-title":"Lancet Child Adolesc"},{"key":"1402_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11864-013-0249-1","volume":"14","author":"M Rosenfeld","year":"2013","unstructured":"Rosenfeld M, Dalmau J (2013) Diagnosis and management of paraneoplastic neurologic disorders. Curr Treat Options Oncol 14:4","journal-title":"Curr Treat Options Oncol"},{"key":"1402_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00415-005-0882-0","volume":"253","author":"S Shams\u2019ili","year":"2006","unstructured":"Shams\u2019ili S, de Beukelaar J, Gratama JW et al (2006) An uncontrolled trial of Rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol 253:16","journal-title":"J Neurol"},{"key":"1402_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/01.mph.0000212991.64435.f0","volume":"28","author":"MR Pranzatelli","year":"2006","unstructured":"Pranzatelli MR, Tate ED, Travelstead AL et al (2006) Rituximab (anti-CD20) adjunctive therapy for opsoclonus\u2013myoclonus syndrome. J Pediatr Hematol Oncol 28:585\u2013593","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01402-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-020-01402-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01402-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T23:08:17Z","timestamp":1623971297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-020-01402-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1402"],"URL":"https:\/\/doi.org\/10.1007\/s13760-020-01402-6","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,18]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}